Adverse Effects of Glucocorticoids Flashcards
What are 4 main categories of adverse effects of long term glucocorticoid Tx?
- Fluid/electrolyte imbalances
- Metabolic Changes
- Immune Suppression
- Myopathy
How are AE mediated by fluid/electrolyte imbalances?
- Glucocorticoid excess can stimulate mineralocorticoid actions.
- Direct stimulation of MR by some steroids
- Some evidence of effects (HTN, edema) that are not mediated by MR.
How are AE mediated by metabolic changes?
- Hyperglycemia/ glucosuria
- can be managed w/ diet and insulin.
How are AE mediated by immune suppression?
- Increased susceptibility to infection w/ chronic steroid use.
- Increased risk of peptic ulcer, esp. in conjunction w/ NSAIDs.
How are AE mediated by Myopathy?
- Can occur w/ both acute, high-dose therapy and chronic therapy.
- Proximal limb muscle weakness.
- Can be severe enough to require termination of Tx, and recovery can be slow and incomplete.
- Mechanism unknown, more common w/ fluorinated glucocorticoids (dexamethasone, triamcinolone)
- Twice as common in women.
What is a frequent and serious complication of glucocorticoid therapy?
- Glucocorticoid-induced Osteoporosis.
- 30-50% of all chronically treated patients will develop fractures.
- Ribs and vertebra are most frequent sites of fractures.
How do glucocorticoids decrease bone density?
- Inhibition of bone formation
- Suppression of osteoblasts, stimulation of osteoclasts. - Suppression of sex steroid hormone synthesis
- Androgens are especially important here, but androgen/estrogen therapy to maintain bone mass has not been shown effective. - Decreased GI absorption of Ca.
- Compensatory increase in PTH, which promotes bone resorption.
- Does NOT appear to involve effects on calcitriol synthesis.
When does bone loss begin while on glucocorticoids therapy?
- first 6 months.
- Pt should have baseline bone density scan upon initiation of therapy.
- Maintain high Ca intake: 1500 mg/day + Vit D (600 IU/d)
- Prolonged use of loop diuretics may aggravate fracture risk.
What can prevent bone loss?
- Bisphosphates
- Pyrophosphate analogs, bind Ca in bones and prevent resorption.
- Fosamax (Alendronate) and Actonel (Risendronate) approved for glucocorticoid-induced osteoporosis.
What two drugs are approved for Tx of glucocorticoid induced osteoporosis?
- Fosamax (Alendronate)
2. Actonel (Risendronate)
What characterizes Osteonecrosis?
- Typically affects Femoral Head, Humoral Head and Distal Femur.
- Relatively common complication of chronic therapy
- unknown cause - Should be considered in patients complaining of joint pain in hip, shoulder, knee.
- Can occur w/ high doses for short periods.
- progresses to joint replacement.
What characterizes Cataracts (posterior sub-capsular)?
- Well-established complication of glucocorticoid therapy.
- Children especially susceptible
- Cataracts may not regress upon cessation of therapy.
- Patients on chronic therapy should have regular eye exams.
What characterizes behavioral changes?
- Many forms: nervousness, insomnia, mood, even psychosis.
- Suicidal tendencies
- Previous psychiatric illness does not preclude, or predict glucocorticoid induced psychiatric disorders.
Can glucocorticoids retard growth in children?
YES
- effects on growth have been demonstrated w/ low-to-moderate chronic glucocorticoid treatment.
- Oral steroids are of greatest concern.
- Use in CAH requires careful monitoring to establish and maintain normal cortisol levels.
Why is use of steroids in chronic asthma children a common concern?
- Inhaled glucocorticoids now shown to cause an initial slowing in growth of prepubertal children.
- 1.2 cm height deficit in adults
- slowing is only first 2 years and not cumulative w/ continued use. - Cromolyns can be used in place of steroids
- Also antileukotrienes (Montelukast-sigulair) - Use of oral steroids for severe chronic asthma should be adjusted to Minimal Effective Dose.
- Use of non-steroidal agens can also be included.
- Cromolyn Na, Nedocromil, Montelukast.
Why can sudden withdrawal from glucocorticoid therapy be life-threatening?
- Acute adrenal insufficiency can occur due to suppression of hypothalamic-pituitary-adrenal axis.
- Recovery typically takes weeks-months; in some cases up to a year.
- Patients that have been treated w/ supraphysiological levels of glucocorticoids for 2-4 weeks in previous year may have some level of HPA suppression. - Patients are unable to handle stressful situations: surgery,injury, illness.
- Can experience severe hypotension, NVD, severe pain in lower back and legs.
At termination of treatment what is done to the dosing of glucocorticoids?
- Usually reduced slowly over 1-2 weeks or longer depending on length of treatment.
- Signs of adrenal insufficiency should be noted:
- NV, malaise - Withdrawal symptoms can also occur.
- Similar symptoms: fever, muscle, joint pain.
- rarely, increased intracranial pressure.
What is Cushing’s syndrome also called?
Hypercortisolism.
What is the Incidence of Cushing’s syndrome?
- Rare disease
2. 0.7-2.4 cases/million/yr (200-700 cases/yr in US)
What is the Etiology of Cushing’s syndrome?
- Pituitary adenomas are most common cause.
- Ectopic ACTH syndrome
- Adrenal Tumors
- Familial Cushing’s syndrome
- Drug-induced hypercortisolism- common.
What is characteristic of Pituitary adenomas as a cause of cushings syndrome?
Most common cause
- benign tumors which secrete ACTH.
- 5-fold more common in women than in men.
What is characteristic of Ectopic ACTH syndrome as a cause of Cushings syndrome?
- ACTH release from non-pituitary tumors.
- Most commonly lung small-cell carcinoma, carcinoid tumors.
- 3-fold more common in men
- Also thymomas, pancreatic islet cell tumors, thyroid carcinomas.
What is characteristic of Adrenal Tumors as a cause of Cushing’s syndrome?
- Non-cancerous adrenal adenomas
- Typical onset after age 40 - Rarely, adrenocortical carcinomas
What is characteristic of Familial Cushing’s Syndrome?
- Inherited tendency to develop endocrine gland tumors that secrete cortisol.
- May be more common than realized in Type 2 DM, obesity, hypertension.